Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) exhibits CD5 immunoreactivity: new evidence for thymic differentiation
Aims: Cases of intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus‐like differentiation (CASTLE) were examined for CD5 immunoreactivity, a feature of true thymic carcinoma, but not other thymic epithelial neoplasms or carcinomas of other sites. ITET/CASTLE, a rare, low‐grade malignant...
Saved in:
Published in | Histopathology Vol. 32; no. 2; pp. 104 - 109 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Oxford, U.K. and Cambridge, USA
Blackwell Science Ltd
01.02.1998
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aims:
Cases of intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus‐like differentiation (CASTLE) were examined for CD5 immunoreactivity, a feature of true thymic carcinoma, but not other thymic epithelial neoplasms or carcinomas of other sites. ITET/CASTLE, a rare, low‐grade malignant neoplasm arising within the thyroid gland which resembles lymphoepithelioma‐like and squamous cell carcinoma of the thymus, is postulated to arise from remnants of branchial pouch capable of thymic differentiation, but thymic differentiation in this neoplasm remains unproven.
Methods and results:
The largest published series of cases of ITET/CASTLE was examined for CD5 immunoreactivity using an anti‐CD5 antibody reactive in fixed, paraffin‐embedded tissue with microwave antigen retrieval. Neoplastic cells in all five cases of ITET/CASTLE studied were immunoreactive for CD5, including foci of tumour metastatic to lymph node and lung. In contrast, none of five cases of thyroid carcinoma with squamous differentiation was immunoreactive for CD5. A minority of cases of typical thyroid carcinomas showed some weak immunoreactivity for CD5. Other carcinomas of the head and neck were non‐immunoreactive for CD5.
Conclusions:
CD5 immunoreactivity in ITET/CASTLE is new evidence in support of thymic differentiation in this neoplasm. |
---|---|
AbstractList | Aims:
Cases of intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus‐like differentiation (CASTLE) were examined for CD5 immunoreactivity, a feature of true thymic carcinoma, but not other thymic epithelial neoplasms or carcinomas of other sites. ITET/CASTLE, a rare, low‐grade malignant neoplasm arising within the thyroid gland which resembles lymphoepithelioma‐like and squamous cell carcinoma of the thymus, is postulated to arise from remnants of branchial pouch capable of thymic differentiation, but thymic differentiation in this neoplasm remains unproven.
Methods and results:
The largest published series of cases of ITET/CASTLE was examined for CD5 immunoreactivity using an anti‐CD5 antibody reactive in fixed, paraffin‐embedded tissue with microwave antigen retrieval. Neoplastic cells in all five cases of ITET/CASTLE studied were immunoreactive for CD5, including foci of tumour metastatic to lymph node and lung. In contrast, none of five cases of thyroid carcinoma with squamous differentiation was immunoreactive for CD5. A minority of cases of typical thyroid carcinomas showed some weak immunoreactivity for CD5. Other carcinomas of the head and neck were non‐immunoreactive for CD5.
Conclusions:
CD5 immunoreactivity in ITET/CASTLE is new evidence in support of thymic differentiation in this neoplasm. AIMSCases of intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) were examined for CD5 immunoreactivity, a feature of true thymic carcinoma, but not other thymic epithelial neoplasms or carcinomas of other sites. ITET/CASTLE, a rare, low-grade malignant neoplasm arising within the thyroid gland which resembles lymphoepithelioma-like and squamous cell carcinoma of the thymus, is postulated to arise from remnants of branchial pouch capable of thymic differentiation, but thymic differentiation in this neoplasm remains unproven.METHODS AND RESULTSThe largest published series of cases of ITET/CASTLE was examined for CD5 immunoreactivity using an anti-CD5 antibody reactive in fixed, paraffin-embedded tissue with microwave antigen retrieval. Neoplastic cells in all five cases of ITET/CASTLE studied were immunoreactive for CD5, including foci of tumour metastatic to lymph node and lung. In contrast, none of five cases of thyroid carcinoma with squamous differentiation was immunoreactive for CD5. A minority of cases of typical thyroid carcinomas showed some weak immunoreactivity for CD5. Other carcinomas of the head and neck were nonimmunoreactive for CD5.CONCLUSIONSCD5 immunoreactivity in ITET/CASTLE is new evidence in support of thymic differentiation in this neoplasm. Cases of intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) were examined for CD5 immunoreactivity, a feature of true thymic carcinoma, but not other thymic epithelial neoplasms or carcinomas of other sites. ITET/CASTLE, a rare, low-grade malignant neoplasm arising within the thyroid gland which resembles lymphoepithelioma-like and squamous cell carcinoma of the thymus, is postulated to arise from remnants of branchial pouch capable of thymic differentiation, but thymic differentiation in this neoplasm remains unproven. The largest published series of cases of ITET/CASTLE was examined for CD5 immunoreactivity using an anti-CD5 antibody reactive in fixed, paraffin-embedded tissue with microwave antigen retrieval. Neoplastic cells in all five cases of ITET/CASTLE studied were immunoreactive for CD5, including foci of tumour metastatic to lymph node and lung. In contrast, none of five cases of thyroid carcinoma with squamous differentiation was immunoreactive for CD5. A minority of cases of typical thyroid carcinomas showed some weak immunoreactivity for CD5. Other carcinomas of the head and neck were nonimmunoreactive for CD5. CD5 immunoreactivity in ITET/CASTLE is new evidence in support of thymic differentiation in this neoplasm. |
Author | Dorfman Shahsafaei Miyauchi |
Author_xml | – sequence: 1 givenname: D. M surname: DORFMAN fullname: DORFMAN, D. M organization: Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States – sequence: 2 givenname: A surname: SHAHSAFAEI fullname: SHAHSAFAEI, A organization: Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States – sequence: 3 givenname: A surname: MIYAUCHI fullname: MIYAUCHI, A organization: Second Department of Surgery, Kagawa Medical University, Kagawa, Japan |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2171900$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9543665$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkcFuEzEQhi1UVNLAIyD5gFB72K29zq7XiEsV0jZSVBAN4mi59ixxuusN9qZJXojnxJtEOXDiNKOZ7_9H9n-BzlzrACFMSUrJqLheppQVeZLluUipEGVKCKNlun2FBqfFGRoQRkRCaMHfoIsQloRQzrLsHJ2LfMSKIh-gP1PXedUtdr61RtUYVrZbQG1jG4dN2yh8OZ1P5lfXWnltXT8Ii3Zj3a89sA5JbZ8BG1tV4MF1VnW2dfhyfPM4n02uMGwX9sl2AY-_5Ng2zdq1HpTu7Ivtdp-wgw2GF2vAacBV6_emVv_r9xa9rlQd4N2xDtGP28l8fJ_Mvt5NxzezRI9EUSZGj1TBDSvZyAhVGppBLILQvKJUV0ZkYFjeE6oEWmrGBWGKUMJJybkxbIg-HnxXvv29htDJxgYNda0ctOsgueCCxf-MYHkAtW9D8FDJlbeN8jtJiewjkkvZJyH7JGQfkdxHJLdR-v54Y_3UgDkJj5nE_YfjXgWt6sorp204YRnlVESvIfp8wDa2ht1_n5f308fYRHlykNvQwfYkV_5ZxufxXP58uJPZtweWf6e3krC_FmC_3Q |
CitedBy_id | crossref_primary_10_4143_crt_2013_184 crossref_primary_10_1097_00003072_200212000_00002 crossref_primary_10_3389_fonc_2017_00207 crossref_primary_10_1111_j_1365_2559_2005_02217_x crossref_primary_10_1590_S0004_27302008000300016 crossref_primary_10_5106_jjshns_21_69 crossref_primary_10_2995_jacsurg_24_742 crossref_primary_10_18632_oncotarget_11914 crossref_primary_10_5858_2001_125_0781_COISOD crossref_primary_10_1007_s00595_013_0560_2 crossref_primary_10_2468_jbes_56_365 crossref_primary_10_1111_j_1440_1827_2011_02745_x crossref_primary_10_1016_j_prp_2021_153646 crossref_primary_10_1016_j_amsu_2019_06_013 crossref_primary_10_1002_dc_21399 crossref_primary_10_1002_dc_21511 crossref_primary_10_1054_cdip_2000_0031 crossref_primary_10_1016_j_anndiagpath_2023_152221 crossref_primary_10_1016_S1607_551X_09_70020_8 crossref_primary_10_1046_j_1365_2559_2001_01207_x crossref_primary_10_1097_RLU_0000000000000788 crossref_primary_10_1177_106689690601400214 crossref_primary_10_1259_bjr_20150726 crossref_primary_10_1007_s12105_019_01098_y crossref_primary_10_1016_j_thscie_2023_100004 crossref_primary_10_1007_s12022_013_9290_7 crossref_primary_10_1007_s12022_020_09635_0 crossref_primary_10_1111_apm_12017 crossref_primary_10_1111_j_1440_1827_2008_02310_x crossref_primary_10_3389_fonc_2022_923683 crossref_primary_10_3803_jkes_2008_23_4_272 crossref_primary_10_1111_j_0303_6987_2004_00235_x crossref_primary_10_1080_00313020601024086 crossref_primary_10_1016_j_humpath_2011_05_003 crossref_primary_10_1002_dc_24281 crossref_primary_10_5631_jibirin_105_357 crossref_primary_10_1089_thy_2007_0262 crossref_primary_10_1016_j_ejso_2006_09_016 crossref_primary_10_1177_1066896920941604 crossref_primary_10_5106_jjshns_20_167 crossref_primary_10_1507_endocrj_51_237 crossref_primary_10_2482_haigan_57_292 crossref_primary_10_1089_thy_2005_15_1383 crossref_primary_10_1097_00000478_200608000_00010 crossref_primary_10_1007_s12253_014_9772_z crossref_primary_10_1016_j_prp_2013_06_021 crossref_primary_10_1159_000448836 crossref_primary_10_9738_INTSURG_D_12_00034_1 crossref_primary_10_3892_ol_2015_4055 crossref_primary_10_1111_j_1365_2559_2006_02451_x crossref_primary_10_1089_thy_2011_0415 crossref_primary_10_1017_S0022215110000551 crossref_primary_10_1507_endocrj_K07E_102 crossref_primary_10_35420_jcohns_2015_26_2_307 crossref_primary_10_1002_jcu_21997 crossref_primary_10_1155_2016_7962385 crossref_primary_10_1002_1097_0142_20000801_89_3_664__AID_CNCR23_3_0_CO_2_S crossref_primary_10_1002_hed_20237 |
ContentType | Journal Article |
Copyright | 1998 INIST-CNRS |
Copyright_xml | – notice: 1998 INIST-CNRS |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1046/j.1365-2559.1998.00318.x |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2559 |
EndPage | 109 |
ExternalDocumentID | 10_1046_j_1365_2559_1998_00318_x 9543665 2171900 HIS318 ark_67375_WNG_2PN35R1F_0 |
Genre | article Journal Article |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29I 31~ 33P 36B 3SF 3UE 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAJUZ AAKAS AANLZ AAONW AASGY AAVGM AAXRX AAZKR ABCQN ABCUV ABCVL ABDBF ABEML ABHUG ABJNI ABOCM ABPTK ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFVGU AFZJQ AGJLS AHBTC AHEFC AIACR AIAGR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA GSXLS H.X HF~ HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 Y6R YFH YOC YUY ZA5 ZGI ZXP ZZTAW ~IA ~WT AITYG HGLYW OIG AAPBV AAUGY IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4968-dc4a67d3834d9a8d12e9a89015f11cfd92ed3567d3a8e18c37903a01070877dd3 |
IEDL.DBID | DR2 |
ISSN | 0309-0167 |
IngestDate | Fri Aug 16 03:56:35 EDT 2024 Fri Aug 23 02:16:21 EDT 2024 Sat Sep 28 08:41:13 EDT 2024 Sun Oct 29 17:09:21 EDT 2023 Sat Aug 24 00:54:11 EDT 2024 Wed Jan 17 05:02:13 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Endocrinopathy Human Immunohistochemistry Carcinoma Thyroid diseases Histiogenesis Thyroid gland Malignant tumor Thymus pathology Case study Pathology Adult Malignant thymoma |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4968-dc4a67d3834d9a8d12e9a89015f11cfd92ed3567d3a8e18c37903a01070877dd3 |
Notes | ark:/67375/WNG-2PN35R1F-0 ArticleID:HIS318 istex:4D94438F3BE807BD99A68C7D5B9C10D0F405FD88 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 9543665 |
PQID | 79793167 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_79793167 crossref_primary_10_1046_j_1365_2559_1998_00318_x pubmed_primary_9543665 pascalfrancis_primary_2171900 wiley_primary_10_1046_j_1365_2559_1998_00318_x_HIS318 istex_primary_ark_67375_WNG_2PN35R1F_0 |
PublicationCentury | 1900 |
PublicationDate | February 1998 |
PublicationDateYYYYMMDD | 1998-02-01 |
PublicationDate_xml | – month: 02 year: 1998 text: February 1998 |
PublicationDecade | 1990 |
PublicationPlace | Oxford, U.K. and Cambridge, USA |
PublicationPlace_xml | – name: Oxford, U.K. and Cambridge, USA – name: Oxford – name: England |
PublicationTitle | Histopathology |
PublicationTitleAlternate | Histopathology |
PublicationYear | 1998 |
Publisher | Blackwell Science Ltd Blackwell |
Publisher_xml | – name: Blackwell Science Ltd – name: Blackwell |
SSID | ssj0017322 |
Score | 1.8143171 |
Snippet | Aims:
Cases of intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus‐like differentiation (CASTLE) were examined for CD5 immunoreactivity, a... Cases of intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) were examined for CD5 immunoreactivity, a feature of... AIMSCases of intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) were examined for CD5 immunoreactivity, a feature... |
SourceID | proquest crossref pubmed pascalfrancis wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 104 |
SubjectTerms | Adult Aged Biological and medical sciences Carcinoma - immunology Carcinoma - pathology CD5 Antigens - analysis Cell Differentiation Endocrinopathies Epithelium - pathology Female Humans immunohistochemistry Male Malignant tumors Medical sciences Middle Aged squamous cell carcinoma Thymoma - pathology thymus Thymus Gland - pathology Thymus Neoplasms - immunology Thymus Neoplasms - pathology thyroid Thyroid Neoplasms - immunology Thyroid Neoplasms - pathology Thyroid. Thyroid axis (diseases) |
Title | Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) exhibits CD5 immunoreactivity: new evidence for thymic differentiation |
URI | https://api.istex.fr/ark:/67375/WNG-2PN35R1F-0/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1365-2559.1998.00318.x https://www.ncbi.nlm.nih.gov/pubmed/9543665 https://search.proquest.com/docview/79793167 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLVQkRAb3hUBCl4g1C4yTGI7D3bV0GGKYITaqejOcmxHRNMm1SQjKlZ8Ap_Bd_El3Os80FRdIMQqUca2MvaxfZx77r2EvNSYZyO0MNNslPgcKKyfCZ75Io9NYMaWGetUvvNodsLfn4rTTv-EvjBtfIjhgxvODLde4wRXWZuFZOyi2_YKLaDE6HKHkkjA5wj5JMbVQ350NESSCmL2x6CAyvtO1NMZOK9taGOnuomdfonKSVVD5-Vt1ovraOkmy3Xb1PQuWfZ_sFWnLEfrJhvpb1diP_6fHrhH7nRslu638LtPbtjyAbn1sbPXPyQ_D_HbMWBhVRUGCtoLdAE5A8xTeHhenSu6C2vnYu-1xpxGJT6ov1RfYT91Bdb1r-8_zoqlpX0il6aFEt2d7B8vPhzsUYsZvoumppO3ghbo7VIBD9ZtUow3FE4N1HaZUykQdNdsoa-294icTA8Wk5nf5YbwNU8BVUZzFcUGztfcpCoxQWjhguQmDwKdmzS0hgksoRIbJJrF6ZgpOHzGGAHRGLZNtsqqtI8JjfJxrIFXMq41Z8ZkcRgpzvNQMZsZzj0S9DiQF20IEOlM9xzd3HAIJA6BxCFwoVYTeemRVw4wQwW1WqKELhby8_ydDD_NmTgKpnLskZ0NRA0V4KgIXA1-f9EjTMLER2uOKm21rmWcwtIKSPbIdgu8oWoqOIsi4RHh0PPXLy1nh8dw8-Qf6z0lt1uHTdT6PCNbzWptd4CxNdlzNxd_A1ivNY0 |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dbtMwFLbQJgE3jL9pAcZ8gdB2ka6J7fxwN5WVFroKbZ3YnZXYjojaJVOTahNXPAKPwXPxJJzjpEWddoEQV61S20rt79jf8fkj5I3COhu-AUkzQeRyoLBuKnjqiizUnu4apo318h0Hg3P-8UJctOWAMBamyQ-xunBDybD7NQo4XkgftmbJRsqtixZwYoy5Q59IAGgHCOUmSL-w-tXpKpeUF7I_JgX0vW_deloT550jrZ1VmzjtN-g7mVQwfVlT9-IuYrrOc-1B1d8is-VfbPxTpp1FnXbUt1vZH__THDwmj1pCS48aBD4h90zxlNw_aU32z8jPIV4fAxzmZa6hobnCKJAZwJ7Cw8vyMqH7sH1ODg4VljUq8EH1tbyGI9U2WFS_vv-Y5VNDl7Vc6gZNdL93dDYZHR9Qg0W-87qivfeC5hjwUgIVVk1djHcUFAdq2uKpFDi6HTZXt8d7Ts77x5PewG3LQ7iKxwAsrXgShBpUbK7jJNKeb-AD-U3meSrTsW80E9giiYwXKRbGXZaA_hliEkSt2TbZKMrC7BAaZN1QAbVkXCnOtE5DP0g4z_yEmVRz7hBvCQR51WQBkdZ6zzHSDZdA4hJIXAKbbTWSNw55axGz6pDMp-hFFwr5ZfxB-p_HTJx6fdl1yO4apFYdQFsEuga_7y0hJkH20aCTFKZcVDKMYXcFKDtku0HeqmssOAsC4RBh4fPXLy0HwzP48uIf--2RB4PJyUiOhuNPL8nDJn4TXX9ekY16vjC7QODq9LUVzN-zSDmv |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dbtMwFLbQJk3cwPiZCGzMFwhtF-ma2PnjbmpXWhjVtHVid5ZjO6LqllRNKiaueAQeg-fiSTjHSYM67QIhrlqldpTa37E_53znHELeKKyz4RuwNBPGLgcK66YBT90gi7Snu4ZpY1W-43B4yT9cBVeN_gljYer8EO0LN7QMu16jgc91dtR4JWsjtwotoMQYcoeSSMBnB_jkJg-Zjwjvn7eppLyI_fEooPS-UfU0Hs5777S2VW3iqN-idFKWMHpZXfbiPl66TnPtPjV4TGarf1jLU2adZZV21Lc7yR__zxBsk0cNnaXHNf6ekAcmf0q2PjUO-2fk5whfHgMYFsVUQ0MzxxiQawA9hYs3xY2kB7B4Tg6PFBY1yvFC-aX4ChuqbbAsf33_cT2dGbqq5FLVWKIHveOLyenJITVY4ntalbTXD-gUw10KIMKqrorxjsKxgZqmdCoFhm5vO1V37_ecXA5OJr2h2xSHcBVPAFZacRlGGg7YXCcy1p5v4APZTeZ5KtOJbzQLsIWMjRcrFiVdJuH0GWEKRK3ZDtnIi9y8IDTMupECYsm4UpxpnUZ-KDnPfMlMqjl3iLfCgZjXOUCE9d1zjHPDKRA4BQKnwOZajcWtQ95awLQd5GKGGrooEJ_H74V_NmbBuTcQXYfsrSGq7QBnRSBr8Pv-CmECLB_dOTI3xbIUUQJrKyDZITs18NquScBZGAYOCSx6_vqhxXB0AV9e_mO_fbJ11h-I09H44yvysA7eRN3PLtmoFkuzB-ytSl9bs_wN0p84Xg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intrathyroidal+epithelial+thymoma+%28ITET%29%2Fcarcinoma+showing+thymus-like+differentiation+%28CASTLE%29+exhibits+CD5+immunoreactivity+%3A+new+evidence+for+thymic+differentiation&rft.jtitle=Histopathology&rft.au=DORFMAN%2C+D.+M&rft.au=SHAHSAFAEI%2C+A&rft.au=MIYAUCHI%2C+A&rft.date=1998-02-01&rft.pub=Blackwell&rft.issn=0309-0167&rft.eissn=1365-2559&rft.volume=32&rft.issue=2&rft.spage=104&rft.epage=109&rft_id=info:doi/10.1046%2Fj.1365-2559.1998.00318.x&rft.externalDBID=n%2Fa&rft.externalDocID=2171900 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0309-0167&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0309-0167&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0309-0167&client=summon |